Progressive spinal axonal degeneration and slowness in ALS2-deficient mice

Annals of Neurology

Volumn 60, Issue 1, 2006, Pages 95-104

  Yamanaka, Koji ^a,b   Miller, Timothy M ^a   McAlonis Downes, Melissa ^a   Chun, Seung Joo ^a   Cleveland, Don W ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUPEROXIDE DISMUTASE;

ALS2 GENE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CONTROLLED STUDY; DEGENERATIVE DISEASE; GENE; GENE MUTATION; GENE TARGETING; MOTOR NEURON DISEASE; MOTOR PERFORMANCE; MOUSE; MUSCLE WEAKNESS; NERVE FIBER DEGENERATION; NONHUMAN; PRIORITY JOURNAL; SPASTIC PARESIS; SPINAL NERVE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; AXONS; FEMALE; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HOMOZYGOTE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICE, NEUROLOGIC MUTANTS; MOTOR NEURONS; MOVEMENT; MUTATION; NERVE DEGENERATION; PHENOTYPE; SPASTIC PARAPLEGIA, HEREDITARY; SPINAL CORD; SUPEROXIDE DISMUTASE;

EID: 33745728401     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20888     Document Type: Article

References (35)

1. Cleveland DW, Rothstein JD. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2001;2:806-819.
2. Bruijn LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 2004;27:723-749.
3. Hentati A, Bejaoui K, Pericak-Vance MA, et al. Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33-q35. Nat Genet 1994;7:425-428.
4. Hosler BA, Sapp PC, Berger R, et al. Refined mapping and characterization of the recessive familial amyotrophic lateral sclerosis locus (ALS2) on chromosome 2q33. Neurogenetics 1998;2:34-42.
5. Hadano S, Nichol K, Brinkman RR, et al. A yeast artificial chromosome-based physical map of the juvenile amyotrophic lateral sclerosis (ALS2) critical region on human chromosome 2q33-q34. Genomics 1999;55:106-112.
6. Hadano S, Hand CK, Osuga H, et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet 2001;29:166-173.
7. Yang Y, Hentati A, Deng HX, et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet 2001;29:160-165.
8. Ben Hamida M, Hentati F, Ben Hamida C. Hereditary motor system diseases (chronic juvenile amyotrophic lateral sclerosis). Conditions combining a bilateral pyramidal syndrome with limb and bulbar amyotrophy. Brain 1990;113(pt 2):347-363.
9. Eymard-Pierre E, Lesca G, Dollet S, et al. Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene. Am J Hum Genet 2002;71:518-527.
10. Gros-Louis F, Meijer IA, Hand CK, et al. An ALS2 gene mutation causes hereditary spastic paraplegia in a Pakistani kindred. Ann Neurol 2003;53:144-145.
11. Devon R, Helm J, Rouleau G, et al. The first nonsense mutation in alsin results in a homogeneous phenotype of infantile-onset ascending spastic paralysis with bulbar involvement in two siblings. Clin Genet 2003;64:210-215.
12. Lerman-Sagie T, Filiano J, Smith DW, Korson M. Infantile onset of hereditary ascending spastic paralysis with bulbar involvement. J Child Neurol 1996;11:54-57.
13. Gascon GG, Chavis P, Yaghmour A, et al. Familial childhood primary lateral sclerosis with associated gaze paresis. Neuropediatrics 1995;26:313-319.
14. Kress JA, Kuhnlein P, Winter P, et al. Novel mutation in the ALS2 gene in juvenile amyotrophic lateral sclerosis. Ann Neurol 2005;58:800-803.
15. Eymard-Pierre E, Yamanaka K, Haeussler M, et al. Novel missense mutation in ALS2 gene results in IAHSP. Ann Neurol 2006;59:976-980.
16. Yamanaka K, Vande Velde C, Eymard-Pierre E, et al. Unstable mutants in the peripheral endosomal membrane component ALS2 cause early-onset motor neuron disease. Proc Natl Acad Sci U S A 2003;100:16041-16046.
17. Otomo A, Hadano S, Okada T, et al. ALS2, a novel guanine nucleotide exchange factor for the small GTPase Rab5, is implicated in endosomal dynamics. Hum Mol Genet 2003;12: 1671-1687.
18. Topp JD, Gray NW, Gerard RD, Horazdovsky BF. Alsin is a Rab5 and Rac1 guanine nucleotide exchange factor. J Biol Chem 2004;279:24612-24623.
19. Kanekura K, Hashimoto Y, Kita Y, et al. A Rac1/phosphatidylinositol 3-kinase/Akt3 anti-apoptotic pathway, triggered by AlsinLF, the product of the ALS2 gene, antagonizes Cu/Zn-superoxide dismutase (SOD1) mutant-induced motoneuronal cell death. J Biol Chem 2005;280:4532-4543.
20. Tudor EL, Perkinton MS, Schmidt A, et al. ALS2/Alsin regulates Rac-PAK signaling and neurite outgrowth. J Biol Chem 2005;280:34735-34740.
21. Hadano S, Benn SC, Kakuta S, et al. Mice deficient in the Rab5 guanine nucleotide exchange factor ALS2/alsin exhibit age-dependent neurological deficits and altered endosome trafficking. Hum Mol Genet 2006;15:233-250.
22. Cai H, Lin X, Xie C, et al. Loss of ALS2 function is insufficient to trigger motor neuron degeneration in knock-out mice but predisposes neurons to oxidative stress. J Neurosci 2005;25: 7567-7574.
23. Merritt HH, Rowland LP. Merritt's textbook of neurology. 10th ed. Philadelphia: Lippincott Williams & Wilkins, 2000.
24. Bradley WG. Neurology in clinical practice. 4th ed. Philadelphia: Butterworth-Heinemann, 2004.
25. Braunwald E. Harrison's principles of internal medicine. 15th ed. New York: McGraw-Hill, 2001.
26. Bruijn LI, Becher MW, Lee MK, et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 1997;18:327-338.
27. Griffiths I, Klugmann M, Anderson T, et al. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 1998;280:1610-1613.
28. Ferreirinha F, Quattrini A, Pirozzi M, et al. Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport. J Clin Invest 2004;113:231-242.
29. Zanjani H, Lemaigre-Dubreuil Y, Tillakaratne NJ, et al. Cerebellar Purkinje cell loss in aging Hu-Bcl-2 transgenic mice. J Comp Neurol 2004;475:481-492.
30. Lesca G, Eymard-Pierre E, Santorelli FM, et al. Infantile ascending hereditary spastic paralysis (IAHSP): clinical features in 11 families. Neurology 2003;60:674-682.
31. Terashima T. Anatomy, development and lesion-induced plasticity of rodent corticospinal tract. Neurosci Res 1995;22: 139-161.
32. Steward O, Zheng B, Ho C, et al. The dorsolateral corticospinal tract in mice: an alternative route for corticospinal input to caudal segments following dorsal column lesions. J Comp Neurol 2004;472:463-477.
33. Reid E. The hereditary spastic paraplegias. J Neurol 1999;246: 995-1003.
34. Yang HW, Lemon RN. An electron microscopic examination of the corticospinal projection to the cervical spinal cord in the rat: lack of evidence for cortico-motoneuronal synapses. Exp Brain Res 2003;149:458-469.
35. Hadano S, Otomo A, Suzuki-Utsunomiya K, et al. ALS2CL, the novel protein highly homologous to the carboxy-terminal half of ALS2, binds to Rab5 and modulates endosome dynamics. FEBS Lett 2004;575:64-70.